Search Results - "VAN NOORD, J. A"

Refine Results
  1. 1

    Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD by van Noord, J. A, Aumann, J-L, Janssens, E, Smeets, J. J, Verhaert, J, Disse, B, Mueller, A, Cornelissen, P. J. G

    Published in The European respiratory journal (01-08-2005)
    “…This study compared the bronchodilator effects of tiotropium, formoterol and both combined in chronic obstructive pulmonary disease (COPD). A total of 71 COPD…”
    Get full text
    Journal Article
  2. 2

    Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium by Vincken, W, van Noord, J.A, Greefhorst, A.P.M, Bantje, Th.A, Kesten, S, Korducki, L, Cornelissen, P.J.G

    Published in The European respiratory journal (01-02-2002)
    “…Tiotropium, a novel once-daily inhaled anticholinergic, has been shown to improve lung function over a 24-h period. In order to extend these findings,…”
    Get full text
    Journal Article
  3. 3

    Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma by Price, D B, Hernandez, D, Magyar, P, Fiterman, J, Beeh, K M, James, I G, Konstantopoulos, S, Rojas, R, van Noord, J A, Pons, M, Gilles, L, Leff, J A

    Published in Thorax (01-03-2003)
    “…Background: Inhaled corticosteroids (ICS) affect many inflammatory pathways in asthma but have little impact on cysteinyl leukotrienes. This may partly explain…”
    Get full text
    Journal Article
  4. 4

    A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease by van Noord, J A, Bantje, Th A, Eland, M E, Korducki, L, Cornelissen, P J G

    Published in Thorax (01-04-2000)
    “…BACKGROUND A study was undertaken to evaluate and compare the efficacy and safety of tiotropium and ipratropium during long term treatment in patients with…”
    Get full text
    Journal Article
  5. 5

    An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting by RUTTEN-VAN MÖLKEN, M, ROOS, B, VAN NOORD, J. A

    Published in Thorax (01-11-1999)
    “…The Chronic Respiratory Questionnaire (CRQ) and the St George's Respiratory Questionnaire (SGRQ) are the two most widely used quality of life questionnaires in…”
    Get full text
    Journal Article
  6. 6

    Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium by van Noord, JA, de Munck, DR, Bantje, TA, Hop, WC, Akveld, ML, Bommer, AM

    Published in The European respiratory journal (01-05-2000)
    “…The efficacy and safety of salmeterol alone was compared with the combination of salmeterol plus ipratropium and with placebo during long‐term treatment in…”
    Get full text
    Journal Article
  7. 7

    Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease by van Noord, J.A, Smeets, J.J, Custers, F.L.J, Korducki, L, Cornelissen, P.J.G

    Published in The European respiratory journal (01-04-2002)
    “…Tiotropium (Spiriva) is a new once-daily inhaled anticholinergic that has its effect through prolonged muscarinic (M)3 receptor antagonism. It has a clinically…”
    Get full text
    Journal Article
  8. 8

    Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease by Hohlfeld, J.M., Sharma, A., van Noord, J.A., Cornelissen, P.J.G., Derom, E., Towse, L., Peterkin, V., Disse, B.

    Published in Journal of clinical pharmacology (01-04-2014)
    “…The aim of the study was to characterize pharmacokinetics of tiotropium solution 5 µg compared to powder 18 µg and assess dose‐dependency of tiotropium…”
    Get full text
    Journal Article
  9. 9

    The efficacy of tiotropium administered via Respimat® Soft Mist™ Inhaler or HandiHaler® in COPD patients by van Noord, J.A, Cornelissen, P.J.G, Aumann, J.-L, Platz, J, Mueller, A, Fogarty, C

    Published in Respiratory medicine (01-01-2009)
    “…Summary Background Tiotropium, a once daily inhaled anticholinergic delivered via HandiHaler® , provides bronchodilation for >24 h and improves patient-centred…”
    Get full text
    Journal Article
  10. 10

    Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms by van Noord, J.A, Aumann, J.-L, Janssens, E, Smeets, J.J, Zaagsma, J, Mueller, A, Cornelissen, P.J.G

    Published in Respiratory medicine (01-07-2010)
    “…Summary Background Clinical information on 24-h spirometric efficacy of combining tiotropium and salmeterol compared to single-agent therapy is lacking in…”
    Get full text
    Journal Article
  11. 11

    Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma by van Noord, J A, Schreurs, A J M, Mol, S J M, Mulder, P G H

    Published in Thorax (01-03-1999)
    “…BACKGROUND The objective of this multicentre, randomised, double blind, parallel group study was to compare the efficacy and safety of the addition of…”
    Get full text
    Journal Article
  12. 12

    Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic bronchitis by SOLER, M, LODE, H, BALDWIN, R, LEVINE, J. H. A, SCHREURS, A. J. M, VAN NOORD, J. A, MAESEN, F. P. V, ZEHRERON, M

    “…Antimicrobial therapy can have a significant impact in the treatment of acute infectious exacerbations in patients with chronic bronchitis, in whom repeated…”
    Get full text
    Journal Article
  13. 13

    One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease by Oostenbrink, J.B, Rutten-van Molken, M.P.M.H, Al, M.J, Van Noord, J.A, Vincken, W

    Published in The European respiratory journal (01-02-2004)
    “…The aim of this paper is to assess the health economic consequences of substituting ipratropium with the new, once-daily bronchodilator tiotropium in patients…”
    Get full text
    Journal Article
  14. 14

    A comparison of the onset of action of salbutamol and formoterol in reversing methacholine-induced bronchoconstriction by van Noord, J.A., Smeets, J.J., Maesen, F.P.V.

    Published in Respiratory medicine (01-12-1998)
    “…This single-centre, randomized, double-blind, double-dummy four-way cross-over study in 24 moderately severe asthmatic patients compared the speed of onset of…”
    Get full text
    Journal Article
  15. 15

    Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action by van Noord, JA, Smeets, JJ, Raaijmakers, JA, Bommer, AM, Maesen, FP

    Published in The European respiratory journal (01-08-1996)
    “…We evaluated the profile of the bronchodilatory effect of three inhaled beta2-agonists, 24 microg formoterol, 50 microg salmeterol and 200 microg salbutamol,…”
    Get full text
    Journal Article
  16. 16

    Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer by SULZER, M. A, LEERS, M. P. G, VAN NOORD, J. A, BOLLEN, E. C. M, THEUNISSEN, P. H. M. H

    “…E-cadherin is a calcium-dependent, epithelial cell adhesion molecule whose reduced expression has been associated with tumor dedifferentiation and increased…”
    Get full text
    Journal Article
  17. 17

    24-hour bronchodilation following a single dose of the novel β(2)-agonist olodaterol in COPD by van Noord, J A, Smeets, J J, Drenth, B M, Rascher, J, Pivovarova, A, Hamilton, A L, Cornelissen, P J G

    Published in Pulmonary pharmacology & therapeutics (01-12-2011)
    “…Current guidelines recommend long-acting bronchodilators as maintenance therapy in COPD when symptoms are not adequately controlled with short-acting agents…”
    Get full text
    Journal Article
  18. 18

    Primary extranodal non-Hodgkin's lymphoma of the lung presenting with bilateral, patchy infiltrates dramatically improving after corticosteroid therapy by Boon, E S, Graal, M B, van Noord, J A

    Published in Chest (01-10-1993)
    “…A 63-year-old man was admitted to the hospital with fever and bilateral, peripheral infiltrates. Infectious disease and malignancy seemed to be excluded by…”
    Get more information
    Journal Article
  19. 19

    Effect of rib cage and abdominal restriction on total respiratory resistance and reactance by van Noord, J A, Demedts, M, Clément, J, Cauberghs, M, Van de Woestijne, K P

    Published in Journal of applied physiology (1985) (01-11-1986)
    “…In 14 healthy male subjects we studied the effects of rib cage and abdominal strapping on lung volumes, airway resistance (Raw), and total respiratory…”
    Get more information
    Journal Article
  20. 20

    Comparison of dynamic lung function indices during forced and quiet breathing in upper airway obstruction, asthma, and emphysema by Mellisant, C F, Van Noord, J A, Van de Woestijne, K P, Demedts, M

    Published in Chest (01-07-1990)
    “…We compared the dynamic lung function indices in patients with asthma (n = 27), emphysema (n = 20), and UAO (n = 18), with the purpose being to examine whether…”
    Get more information
    Journal Article